Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersOtolaryngology Physician in Rancho Mirage, CA
NPI: 1134224280Primary Practice Location
EISENHOWER MEDICAL CENTER
39000 Bob Hope Dr, Rancho Mirage, CA
Primary Employer
Desert Ear, Nose & Throat Medical Group, Inc.
desertent.org
HQ Phone
Get MEDICAL DORCTOR Quinten's Phone Numberphone_androidMobile
Get MEDICAL DORCTOR Quinten's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
OR State Medical License
1997
CA State Medical License
1993 - 2026
American Board of Otolaryngology - Head and Neck Surgery
Otolaryngology
UCLA David Geffen School of Medicine/UCLA Medical Center
Residency • Otolaryngology - Head and Neck Surgery
1991 - 1997
David Geffen School of Medicine at UCLA
medschool.ucla.edu
Medical School
Until 1991
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 488 | 618 |
| 2 | 31231Diagnostic examination of nasal passages using an endoscope | 455 | 584 |
| 3 | 69210Removal of impact ear wax, one ear | 387 | 424 |
| 4 | 31575Diagnostic examination of voice box using flexible endoscope | 344 | 432 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 312 | 361 |
Cisplatinum and interstitial laser therapy for advanced head and neck cancer: A preclinical study
Authors: Adrien Eshraghi
Laser photochemotherapy with anthracyclines on cultured human squamous carcinoma
Authors: Marcos B. Paiva, Romaine E. Saxton, G. St. A. Letts, Phil-Sang Chung, J.
Publication Date: 1996-03
Hypericin: A New Laser Phototargeting Agent for Human Cancer Cells†‡
Authors: Quinten M. Vanderwerf, Romaine E. Saxton, Andrew Chang, Dennis Horton, Marcos B. Paiva
